Loading…
Screening, Synthesis and Biochemical Characterization of SARS-CoV-2 Protease Inhibitors
The severe acute respiratory syndrome-causing coronavirus 2 (SARS-CoV-2) papain-like protease (PL ) and main protease (M ) play an important role in viral replication events and are important targets for anti-coronavirus drug discovery. In search of these protease inhibitors, we screened a library o...
Saved in:
Published in: | International journal of molecular sciences 2023-08, Vol.24 (17), p.13491 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The severe acute respiratory syndrome-causing coronavirus 2 (SARS-CoV-2) papain-like protease (PL
) and main protease (M
) play an important role in viral replication events and are important targets for anti-coronavirus drug discovery. In search of these protease inhibitors, we screened a library of 1300 compounds using a fluorescence thermal shift assay (FTSA) and identified 53 hits that thermally stabilized or destabilized PL
. The hit compounds structurally belonged to two classes of small molecules: thiazole derivatives and symmetrical disulfide compounds. Compound dissociation constants (K
) were determined using an enzymatic inhibition method. Seven aromatic disulfide compounds were identified as efficient PL
inhibitors with K
values in the micromolar range. Two disulfides displayed six-fold higher potency for PL
(K
= 0.5 µM) than for M
. The disulfide derivatives bound covalently to both proteases, as confirmed through mass spectrometry. The identified compounds can serve as lead compounds for further chemical optimization toward anti-COVID-19 drugs. |
---|---|
ISSN: | 1422-0067 1661-6596 1422-0067 |
DOI: | 10.3390/ijms241713491 |